Skip to main content
Donna Salzman, MD, Oncology, Birmingham, AL

DonnaESalzmanMD

Oncology Birmingham, AL

Hematologic Oncology

Associate Professor, Medicine, University of Alabama School of Medicine

Dr. Salzman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Salzman's full profile

Already have an account?

  • Office

    NP2570
    1720 2nd Ave S
    Birmingham, AL 35294
    Phone+1 205-934-1908
    Fax+1 205-975-8394

Summary

  • Associate Chief of Staff

Education & Training

  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1990 - 1993
  • Louisiana State University School of Medicine
    Louisiana State University School of MedicineResidency, Internal Medicine, 1986 - 1989
  • Louisiana State University School of Medicine in New Orleans
    Louisiana State University School of Medicine in New OrleansClass of 1986

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1995 - 2024
  • LA State Medical License
    LA State Medical License 1986 - 2005
  • TX State Medical License
    TX State Medical License 1991 - 1997
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Late Mortality After Allogeneic Blood or Marrow Transplantation in Childhood for Leukemia: A Report from the Blood or Marrow Transplant Survivor Study-2  
    Stephen J Forman, Daniel J Weisdorf, Donna Salzman, Mukta Arora, Saro H Armenian, Nature
  • Safety of Repeated Un-Manipulated Peripheral Blood Stem Cell Haploidentical Transplant for Graft Failure  
    N Patil, D Salzman, J H Chewning, L Lamb, S Mineishi, Nature

Abstracts/Posters

  • A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrel...
    Donna Salzman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • UAB’s Blood and Marrow Transplantation and Cell Therapy Program Celebrates 30 Years of Patient Care
    UAB’s Blood and Marrow Transplantation and Cell Therapy Program Celebrates 30 Years of Patient CareOctober 29th, 2021
  • BMT Survivor Study Finds Significant Breast Cancer Risk in Young Women Who Received Total Body Irradiation
    BMT Survivor Study Finds Significant Breast Cancer Risk in Young Women Who Received Total Body IrradiationJuly 31st, 2020
  • NASA Light Technology Successfully Reduces Cancer Patients Painful Side Effects from Radiation and Chemotherapy
    NASA Light Technology Successfully Reduces Cancer Patients Painful Side Effects from Radiation and ChemotherapyMarch 7th, 2011

Professional Memberships